UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Modulating ROS to overcome multidrug resistance in cancer

Drug resistance updates, 2018-11, Vol.41, p.1-25

2018

Volltextzugriff (PDF)

Structure and function of ABCG2-rich extracellular vesicles mediating multidrug resistance

PloS one, 2011-01, Vol.6 (1), p.e16007-e16007

2011

Volltextzugriff (PDF)

Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation

Drug resistance updates, 2016-01, Vol.24 (C), p.34-54

2016

Volltextzugriff (PDF)

Molecular basis of resistance to proteasome inhibitors in hematological malignancies

Drug resistance updates, 2015-01, Vol.18, p.18-35

2015

Volltextzugriff (PDF)

Overcoming multidrug resistance via photodestruction of ABCG2-rich extracellular vesicles sequestering photosensitive chemotherapeutics

PloS one, 2012-04, Vol.7 (4), p.e35487-e35487

2012

Volltextzugriff (PDF)

Taxanes in cancer treatment: Activity, chemoresistance and its overcoming

Drug resistance updates, 2021-01, Vol.54, p.100742, Article 100742

2021

Volltextzugriff (PDF)

Chemotherapeutic Drug-Induced ABCG2 Promoter Demethylation as a Novel Mechanism of Acquired Multidrug Resistance

Neoplasia (New York, N.Y.), 2009-12, Vol.11 (12), p.1359,IN10-1370,IN11

2009

Volltextzugriff (PDF)

The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane

Cells (Basel, Switzerland), 2020-04, Vol.9 (5), p.1082

2020

Volltextzugriff (PDF)

Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin

Biochemical pharmacology, 2010-04, Vol.79 (8), p.1108-1117

2010

Volltextzugriff (PDF)

Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs

Drug resistance updates, 2020-05, Vol.50, p.100683, Article 100683

2020

Volltextzugriff (PDF)

Novel nanomedicines to overcome cancer multidrug resistance

Drug resistance updates, 2021-09, Vol.58, p.100777-100777, Article 100777

2021

Volltextzugriff (PDF)

Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance

Drug resistance updates, 2021-01, Vol.54, p.100743-100743, Article 100743

2021

Volltextzugriff (PDF)

Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function

Drug resistance updates, 2021-07, Vol.57, p.100770-100770, Article 100770

2021

Volltextzugriff (PDF)

Therapeutic strategies to overcome taxane resistance in cancer

Drug resistance updates, 2021-03, Vol.55, p.100754, Article 100754

2021

Volltextzugriff (PDF)

Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance

Drug resistance updates, 2011-06, Vol.14 (3), p.150-163

2011

Volltextzugriff (PDF)

Targeted nanomedicine modalities for prostate cancer treatment

Drug resistance updates, 2021-05, Vol.56, p.100762-100762, Article 100762

2021

Volltextzugriff (PDF)

Hallmarks of anticancer and antimicrobial activities of corroles

Drug resistance updates, 2023-03, Vol.67, p.100931-100931, Article 100931

2023

Volltextzugriff (PDF)

Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins

Drug resistance updates, 2017-05, Vol.32, p.23-46

2017

Volltextzugriff (PDF)

Epigenetic enzyme mutations as mediators of anti-cancer drug resistance

Drug resistance updates, 2022-03, Vol.61, p.100821-100821, Article 100821

2022

Volltextzugriff (PDF)

Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance

Drug resistance updates, 2022-09, Vol.64, p.100864, Article 100864

2022

Volltextzugriff (PDF)

Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine

Cell death & disease, 2019-05, Vol.10 (6), p.390, Article 390

2019

Volltextzugriff (PDF)

The Importance of Breast Cancer Resistance Protein to the Kidneys Excretory Function and Chemotherapeutic Resistance

Drug resistance updates, 2017, Vol.30, p.15-27

2017

Volltextzugriff (PDF)

The role of endolysosomal trafficking in anticancer drug resistance

Drug resistance updates, 2021-07, Vol.57, p.100769-100769, Article 100769

2021

Volltextzugriff (PDF)

Repositioning of drugs for intervention in tumor progression and metastasis: Old drugs for new targets

Drug resistance updates, 2016-05, Vol.26, p.10-27

2016

Volltextzugriff (PDF)

Could drugs inhibiting the mevalonate pathway also target cancer stem cells?

Drug resistance updates, 2016-03, Vol.25, p.13-25

2016

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

ThemaAntineoplastic Agents - Pharmacology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Modulating ROS to overcome multidrug resistance in cancer

Structure and function of ABCG2-rich extracellular vesicles mediating multidrug resistance

Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation

Molecular basis of resistance to proteasome inhibitors in hematological malignancies

Overcoming multidrug resistance via photodestruction of ABCG2-rich extracellular vesicles sequestering photosensitive chemotherapeutics

Taxanes in cancer treatment: Activity, chemoresistance and its overcoming

Chemotherapeutic Drug-Induced ABCG2 Promoter Demethylation as a Novel Mechanism of Acquired Multidrug Resistance

The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane

Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin

Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs

Novel nanomedicines to overcome cancer multidrug resistance

Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance

Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function

Therapeutic strategies to overcome taxane resistance in cancer

Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance

Targeted nanomedicine modalities for prostate cancer treatment

Hallmarks of anticancer and antimicrobial activities of corroles

Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins

Epigenetic enzyme mutations as mediators of anti-cancer drug resistance

Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance

Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine

The Importance of Breast Cancer Resistance Protein to the Kidneys Excretory Function and Chemotherapeutic Resistance

The role of endolysosomal trafficking in anticancer drug resistance

Repositioning of drugs for intervention in tumor progression and metastasis: Old drugs for new targets

Could drugs inhibiting the mevalonate pathway also target cancer stem cells?

Aktive Filter

Suchergebnisse filtern